Related references
Note: Only part of the references are listed.Comparing open and robotic salvage radical prostatectomy after radiotherapy: predictors and outcomes
Pablo F. Martinez et al.
PROSTATE INTERNATIONAL (2021)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Prognostic Significance of Young Age and Non-Bone Metastasis at Diagnosis in Patients with Metastatic Prostate Cancer: a SEER Population-Based Data Analysis
Yadong Guo et al.
JOURNAL OF CANCER (2019)
Role of surgery in oligometastatic prostate cancer
Pocharapong Jenjitranant et al.
PROSTATE INTERNATIONAL (2019)
Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer
Bertram E. Yuh et al.
PROSTATE INTERNATIONAL (2019)
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
Silke Gillessen et al.
EUROPEAN UROLOGY (2018)
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Christopher C. Parker et al.
LANCET (2018)
Survival outcomes of younger men (< 55 years) undergoing radical prostatectomy
Lynn Tan et al.
PROSTATE INTERNATIONAL (2018)
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Clinical outcomes in a contemporary series of young patients with castration-resistant prostate cancer who were 60 years and younger
Orazio Caffo et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Metastatic Adenocarcinoma of Prostate in a 28-Year-Old Male: The outcome is poor in young patients?
Renu Madan et al.
INDIAN JOURNAL OF PALLIATIVE CARE (2015)
Prognostic impact of young age on stage IV prostate cancer treated with primary androgen deprivation therapy
Tomokazu Kimura et al.
INTERNATIONAL JOURNAL OF UROLOGY (2014)
Patrón de presentación del cáncer de próstata avanzado en pacientes menores de cincuenta años
J.C. Astigueta et al.
Actas Urologicas Espanolas (2013)
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Impact of Age at Diagnosis on Outcomes in Men with Castrate-Resistant Prostate Cancer (CRPC)
Michael R. Humphreys et al.
JOURNAL OF CANCER (2013)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Impact of Age at Diagnosis on Prostate Cancer Treatment and Survival
Seth K. Bechis et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann Sebastian de Bono et al.
LANCET (2010)
Treatment and Survival Outcomes in Young Men Diagnosed With Prostate Cancer
Daniel W. Lin et al.
CANCER (2009)
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
JI Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
